Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity.

Galen JE, Buskirk AD, Tennant SM, Pasetti MF.

EcoSal Plus. 2016 Nov;7(1). doi: 10.1128/ecosalplus.ESP-0010-2016.

2.

Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.

Dharmasena MN, Feuille CM, Starke CE, Bhagwat AA, Stibitz S, Kopecko DJ.

PLoS One. 2016 Sep 27;11(9):e0163511. doi: 10.1371/journal.pone.0163511. eCollection 2016.

3.

Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.

Wahid R, Fresnay S, Levine MM, Sztein MB.

Clin Immunol. 2016 Dec;173:87-95. doi: 10.1016/j.clim.2016.09.006. Epub 2016 Sep 12.

PMID:
27634430
4.

The Burden of Typhoid and Paratyphoid in India: Systematic Review and Meta-analysis.

John J, Van Aart CJ, Grassly NC.

PLoS Negl Trop Dis. 2016 Apr 15;10(4):e0004616. doi: 10.1371/journal.pntd.0004616. eCollection 2016 Apr. Review.

5.

Challenges and Opportunities for Typhoid Fever Control: A Call for Coordinated Action.

Steele AD, Hay Burgess DC, Diaz Z, Carey ME, Zaidi AK.

Clin Infect Dis. 2016 Mar 15;62 Suppl 1:S4-8. doi: 10.1093/cid/civ976.

6.

Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model.

McArthur MA, Fresnay S, Magder LS, Darton TC, Jones C, Waddington CS, Blohmke CJ, Dougan G, Angus B, Levine MM, Pollard AJ, Sztein MB.

PLoS Pathog. 2015 May 22;11(5):e1004914. doi: 10.1371/journal.ppat.1004914. eCollection 2015 May.

7.

Vaccines against enteric infections for the developing world.

Czerkinsky C, Holmgren J.

Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671). pii: 20150142. doi: 10.1098/rstb.2015.0142. Review.

8.

Use of Ensure® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines.

Brenneman KE, Gonzales A, Roland KL, Curtiss R 3rd.

BMC Microbiol. 2015 Mar 29;15:76. doi: 10.1186/s12866-015-0409-5.

9.
10.

Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward.

Sztein MB, Salerno-Goncalves R, McArthur MA.

Front Immunol. 2014 Oct 27;5:516. doi: 10.3389/fimmu.2014.00516. eCollection 2014. Review.

11.

Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection.

Poles J, Alvarez Y, Hioe CE.

AIDS Res Hum Retroviruses. 2014 Nov;30(11):1027-40. doi: 10.1089/aid.2014.0233. Review.

12.

Vaccines against invasive Salmonella disease: current status and future directions.

MacLennan CA, Martin LB, Micoli F.

Hum Vaccin Immunother. 2014;10(6):1478-93. doi: 10.4161/hv.29054. Epub 2014 May 7. Review.

13.

Commercializing diarrhea vaccines for travelers.

López-Gigosos R, Segura-Moreno M, Díez-Díaz R, Plaza E, Mariscal A.

Hum Vaccin Immunother. 2014;10(6):1557-67. doi: 10.4161/hv.27737. Epub 2014 Feb 4. Review.

14.

25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal.

Bajracharya D, Khan MI, Pach A 3rd, Shrestha P, Joshi N, Upreti SR, Wierzba T, Puri M, Sahastrabuddhe S, Ochiai RL.

PLoS One. 2014 Jan 6;9(1):e77974. doi: 10.1371/journal.pone.0077974. eCollection 2014.

15.

Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA.

Muhsen K, Pasetti MF, Reymann MK, Graham DY, Levine MM.

J Infect Dis. 2014 May 1;209(9):1452-8. doi: 10.1093/infdis/jit625. Epub 2013 Nov 23.

16.

Progress in Brucella vaccine development.

Yang X, Skyberg JA, Cao L, Clapp B, Thornburg T, Pascual DW.

Front Biol (Beijing). 2013 Feb 1;8(1):60-77.

17.

Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.

Kantele A, Pakkanen SH, Karttunen R, Kantele JM.

PLoS One. 2013 Apr 8;8(4):e60583. doi: 10.1371/journal.pone.0060583. Print 2013.

18.

Vaccination for typhoid fever in sub-Saharan Africa.

Slayton RB, Date KA, Mintz ED.

Hum Vaccin Immunother. 2013 Apr;9(4):903-6. doi: 10.4161/hv.23007. Epub 2013 Apr 1. Review.

19.

In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines.

Fiorentino M, Lammers KM, Levine MM, Sztein MB, Fasano A.

Front Immunol. 2013 Feb 12;4:17. doi: 10.3389/fimmu.2013.00017. eCollection 2013.

20.

A mouse model of Salmonella typhi infection.

Mathur R, Oh H, Zhang D, Park SG, Seo J, Koblansky A, Hayden MS, Ghosh S.

Cell. 2012 Oct 26;151(3):590-602. doi: 10.1016/j.cell.2012.08.042.

Supplemental Content

Support Center